Announcements

We are delighted to announce that the Bill and Melinda Gates Foundation (BMGF) is now a participant of our Institutional Open Access Program (IOAP). Authors funded by the BMGF can enjoy discounts on the APC, while the funder covers the costs of eligible articles centrally. BMGF also has access to the MDPI online submission system where they can find full article metadata and pricing information as well as Grant ID details for easy identification and additional transparency.

We hope that funded authors find the programme beneficial and we are happy to offer our IOAP to other funders that need a streamlined workflow of compliance checking and APC coverage. 

To claim their discount, BMGF funded authors should choose the particular funder and add their Grant ID upon online submission of their manuscript.

For any questions about the BMGF agreement, please contact the funder at support@chronos-oa.com or the MDPI IOAP team at ioap@mdpi.com.

MDPI will be attending NanoBio&Med2018, to be held in Barcelona, Spain, 20–22 November 2018.

This conference presents the most recent international developments in the field of Nanobiotechnology and Nanomedicine. Emerging and future trends of the converging fields of Nanotechnology, Biotechnology and Medicine will be discussed among industry, academic, governmental and non-governmental institutions and the conference will provide a platform for multidisciplinary communication.

The following MDPI journals will be represented:

• Bioengineering
• Biomimetics
• Biomolecules
• Journal of Personalized Medicine
• Methods and Protocols

If you are also attending this conference, please feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any question you may have. For more information about the conference, please visit: http://www.nanobiomedconf.com/NBM18/index.php

Recently, it was announced that a group of European funders supported 10 principles that will help to expand open access, known as Plan S. MDPI warmly welcomes this move as a step towards achieving more open and accessible communication of research across all disciplines. Some aspects remain to be clarified, however the details given so far match the aims and values that MDPI has held over the past two decades.

We believe that open access publishers should be active participants in discussions around Plan S, particularly regarding potential new business models and practical aspects of implementation. MDPI supports APCs as a transparent unit of payment for article publishing, however we are committed to exploring other measures and recently signed the Jussieu Call. Sustainability is a key value for MDPI, and future funding models should have at their heart the sustainability of knowledge and research dissemination. Plan S provides an opportunity for funders and publishers to directly discuss funding of open access journals in ways that are beneficial to all parties involved.

We are happy to announce the establishment of an Open Access (OA) agreement with Qatar National Library (QNL). QNL is committed to supporting and helping Qatar authors publish OA at no cost. Through this national agreement, QNL will cover the Article Processing Charges (APC) of manuscripts published by Qatar-based corresponding authors in MDPI journals.

Eligible corresponding authors affiliated with Qatar research centers and universities are prompted to choose QNL as part of our Institutional Open Access Program (IOAP) when they submit an article via our online submission system. The program will be selected automatically if authors submit their papers using their institutional email and/or a computer registered with the institution’s IP range. QNL will then crosscheck the information and confirm the APC funding.

Qatar authors that have their APC covered by QNL are advised to include the following sentence in their acknowledgments: "The publication of this article was funded by Qatar National Library".

For more information, please visit Open Access at QNL or email the QNL Open Access team at openaccess@qnl.qa.

We are pleased to announce that Dr. Vladimir N. Uversky has been appointed Editor-in-Chief of the open access journal Biomolecules (ISSN 2218-273X). Vladimir N. Uversky is an Associate Professor at the Department of Molecular Biology at the University of South Florida. He has a PhD in Biophysics (Moscow Institute of Physics and Technology, 1991), as well as a DSc in Biophysics (Institute of Experimental and Theoretical Biophysics, Russian Academy of Sciences, 1998).

In addition to being the Editor-in-Chief of Biomolecules, Vladimir serves as a Co-Editor-in-Chief for the “Molecular Biophysics” Section of the International Journal of Molecular Sciences (IJMS), an Executive Editor of the Biochemistry and Biophysics Reports; Section Editor for the Biochemistry, Biophysics, Molecular Biology Section of the PeerJ, an Academic Editor for Protein and Peptide; an Associate Editor for the Biochimica et Biophysica Acta—Proteins and Proteomics, Current Protein and Peptide Science, and Frontiers in Protein Folding, Misfolding and Degradation; and an Editorial Board Member of more than 10 journals in the fields of protein science and bioinformatics. He was a Co-Founder and one of the first council members (2007–2010) of the Intrinsically Disordered Proteins Subgroup of the Biophysical Society. He also co-founded the “Intrinsically Disordered Proteins” Gordon Research Conference.

Vladimir’s research interests include experimental studies on protein folding, misfolding and aggregation, as well as experimental and computational characterization of intrinsically disordered proteins (i.e., biologically active without unique structures). His work on different aspects of protein physics has received international recognition. Each year from 2014–2017, he was selected as a Thomson Reuters Highly Cited Researcher.

We warmly welcome Dr. Vladimir N. Uversky as our Editor-in-Chief and look forward to his valuable input for the continued success of Biomolecules.

We are pleased to report Biomolecules received a CiteScore of 5.72 for 2017. The metric reflects citation activity in 2017 in Scopus for papers published in the period 2014‒2016.

Biomolecules ranks in the Top 10% of journals in the 'Biochemistry' category.

For the full details in the current CiteScore release, please see the journal's Source profile. To check the full list of MDPI journals receiving CiteScores, please see here.

The 2017 CiteScore™ data is available now, based on citation data in the Scopus® database. The current CiteScore reflects citation activity in 2017 for articles published in 2014‒2016. Please note that the list below includes journals assigned a CiteScore in this year’s release. For a full list of journals indexed in Scopus, please see our journal list.

Thirteen of our journals received a CiteScore which is in the top 10% of the distribution in at least one of the categories (marked with * in the table below), while a further 32 journals exhibit scores that are in the first quartile of the respective categories.

To access the full data for MDPI journals, please see here. More data can also be found in SJR Scimago Journal & Country Rank.

Unlike CiteScores and the widely used Journal Impact Factors, the Source Normalized Impact per Paper (SNIP) metrics are normalized in order to correct for differences in citation practices between scientific fields. Therefore, the SNIP allows direct comparison between journals specialized in different fields.

According to 2017 data, MDPI publishes six journals with an average citation impact, or SNIP, in excess of 1.500. These journals are Biomolecules, Cancers, Journal of Clinical Medicine (JCM), Marine Drugs, Remote Sensing and Sensors (see the last column in the table below).

CiteScore Data for MDPI Journals

The deadline submission for the special issue "Biomolecules for Translational Approaches in Cardiology" (Editors: Dr. Mahir Karakas, Prof. Dr. Tanja Zeller) has been extended to 31 July 2018.

For more information about the special issue, please visit: https://www.mdpi.com/journal/biomolecules/special_issues/Biomol_Card.